STOCK TITAN

Churchill Capital Corp XII Completes Upsized $414 Million Initial Public Offering

(Neutral)
(Neutral)
Tags

Churchill Capital Corp XII (Nasdaq: CXIIU) closed an upsized initial public offering of 41,400,000 units at $10.00 per unit, including full exercise of a 5,400,000-unit overallotment, generating $414,000,000 in gross proceeds.

Each unit comprises one Class A ordinary share and one-tenth of a redeemable warrant; whole warrants carry a $11.50 exercise price. Proceeds of $414,000,000 were placed in trust pending a business combination. Units began trading April 28, 2026 on Nasdaq under CXIIU.

Loading...
Loading translation...

Positive

  • Gross proceeds of $414,000,000
  • Upsized offering to 41.4 million units including full overallotment
  • Units began trading on Nasdaq under CXIIU
  • Proceeds placed in trust at $10.00 per unit

Negative

  • Redeemable warrants could cause future dilution at $11.50 exercise price
  • No specific business combination target or timeline disclosed

Market Context

This announcement details the completion of an upsized initial public offering, raising $414,000,000...
Analysis

This announcement details the completion of an upsized initial public offering, raising $414,000,000 through 41,400,000 units at $10.00 each, with proceeds placed in trust. Each unit includes one Class A share and one-tenth of a redeemable warrant with an $11.50 exercise price. Investors may focus on how this capital base supports a future business combination, the terms of any eventual transaction, and subsequent regulatory filings or disclosures about potential targets.

Key Figures

Gross proceeds: $414,000,000 Units offered: 41,400,000 units Over-allotment units: 5,400,000 units +5 more
8 metrics
Gross proceeds $414,000,000 Upsized initial public offering
Units offered 41,400,000 units Initial public offering size
Over-allotment units 5,400,000 units Underwriters' over-allotment option exercised in full
IPO price $10.00 per unit Public offering price
Warrant exercise price $11.50 per share Exercise price for each whole warrant
Trust funding $414,000,000 Placed in trust from IPO and over-allotment proceeds
Unit structure 1 share + 0.1 warrant Each unit: one Class A share and one-tenth warrant
SEC effectiveness date April 27, 2026 Registration statements declared effective by SEC

Key Terms

over-allotment option, redeemable warrant, exercise price, private placement, +2 more
6 terms
over-allotment option financial
"includes 5,400,000 units issued pursuant to the exercise by the underwriters of their over-allotment option"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.
redeemable warrant financial
"one Class A ordinary share of the Company and one-tenth of one redeemable warrant"
A redeemable warrant is a financial tool that gives its holder the right to buy shares of a company at a fixed price within a certain period. If the holder chooses to do so, the company can buy back or cancel the warrant before it expires, often to encourage investment or manage share issuance. For investors, it provides an option to potentially buy shares at a favorable price while offering some flexibility for the issuing company.
exercise price financial
"each whole warrant entitling the holder thereof to purchase one Class A ordinary share ... at an exercise price of $11.50 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
private placement financial
"from the consummation of the initial public offering ... and a simultaneous private placement of units"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
prospectus regulatory
"The offering was made by means of a prospectus. Copies of the prospectus may be obtained"
A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.
registration statements regulatory
"Registration statements relating to the securities were declared effective"
Registration statements are detailed documents companies file with securities regulators when they plan to offer shares or other securities to the public. They act like a recipe and instruction manual, listing a company’s business, finances, management, risks and how the offering will work, so investors can judge value and potential downsides. For investors, these filings provide the official, legally required facts needed to make informed decisions and spot warning signs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, NY, April 29, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XII (the “Company”) announced today the closing of its upsized initial public offering of 41,400,000 units, which includes 5,400,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $414,000,000.

The Company’s units began trading on April 28, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CXIIU.” Each unit consists of one Class A ordinary share of the Company and one-tenth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “CXII” and “CXIIW,” respectively.

Of the proceeds received from the consummation of the initial public offering (as well as the exercise of the over-allotment option) and a simultaneous private placement of units, $414,000,000 (or $10.00 per unit sold in the public offering) was placed in trust.

The Company was founded by Michael Klein, who is also the founder and managing partner of M. Klein and Company, LLC. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

Citigroup acted as sole book-running manager for the offering.

The offering was made by means of a prospectus. Copies of the prospectus may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146), or by accessing the SEC’s website at www.sec.gov.

Registration statements relating to the securities were declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 27, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds thereof. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact:  

Churchill Capital Corp XII 
info@churchillcapitalcorp.com
212-380-7500


FAQ

How many units did Churchill Capital Corp XII (CXIIU) sell in its IPO on April 28, 2026?

Churchill Capital sold 41,400,000 units in the upsized IPO, including a 5,400,000-unit overallotment exercise. According to the company, the units were priced at $10.00 per unit, producing gross proceeds of $414,000,000.

What securities make up each Churchill Capital CXIIU unit and the warrant terms?

Each unit contains one Class A ordinary share and one-tenth of a redeemable warrant. According to the company, each whole warrant entitles the holder to buy one share at an $11.50 exercise price when separate trading begins.

Where and when did Churchill Capital Corp XII (CXIIU) begin trading after its IPO?

The company's units began trading on the Nasdaq Global Market on April 28, 2026 under the ticker CXIIU. According to the company, Class A shares and warrants are expected to trade separately as CXII and CXIIW once separated.

How much of the IPO proceeds were placed in trust by Churchill Capital Corp XII (CXII)?

The company placed $414,000,000 in trust, equal to $10.00 per unit sold in the public offering. According to the company, these funds will be held pending completion of a qualifying business combination.

Who sponsored Churchill Capital Corp XII (CXII) and what is the company's stated purpose?

Churchill Capital Corp XII was founded by Michael Klein, founder and managing partner of M. Klein and Company. According to the company, it was formed to pursue a business combination with one or more target companies in any industry.